Genetic polymorphisms in IL-7 and IL-7R are correlated with lung cancer risk in the Chinese Han population

References

• Siegel RLMK, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.2155130620402
   PubMed Web of Science ®Google Scholar
• Cao M, Chen W. Epidemiology of lung cancer in China. Thorac Cancer. 2019;10(1):3–7. doi:10.1111/1759-7714.1291630485694
   PubMed Web of Science ®Google Scholar
• Martín-Sánchez JCLN, González-Marrón A, Lidón-Moyano C, et al. Projections in breast and lung cancer mortality among women: a bayesian analysis of 52 countries worldwide. Cancer Res. 2018;78(15):4436–4442. doi:10.1158/0008-5472.CAN-18-018730068667
   PubMed Web of Science ®Google Scholar
• Gibelin CCS. Somatic alterations in lung cancer: do environmental factors matter? Lung Cancer. 2016;100:45–52. doi:10.1016/j.lungcan.2016.07.01527597280
   PubMed Web of Science ®Google Scholar
• Gouvinhas CDMR, Oliveira D, Castro-Lopes JM, et al. Lung cancer: a brief review of epidemiology and screening. Future Oncol. 2018;14(6):567–575. doi:10.2217/fon-2017-048629417838
   PubMed Web of Science ®Google Scholar
• Clemenceau ABO, Landry-Truchon K, Lamontagne M, et al. Lung cancer susceptibility genetic variants modulate HOXB2 expression in the lung. Int J Dev Biol. 2018;62(11–12):857–864. doi:10.1387/ijdb.180210yb30604855
   PubMed Web of Science ®Google Scholar
• Pintarelli G, Cotroneo CE, Noci S, et al. Genetic susceptibility variants for lung cancer: replication study and assessment as expression quantitative trait loci. Sci Rep. 2017;7:42185. doi:10.1038/srep4218528181565
   PubMed Web of Science ®Google Scholar
• Wu LLJ, Xu HL, Xu B, Tong XH, Kwak-Kim J, Liu YS. IL-7/IL-7R signaling pathway might play a role in recurrent pregnancy losses by increasing inflammatory Th17 cells and decreasing Treg cells. Am J Reprod Immunol. 2016;76(6):454–464. doi:10.1111/aji.1258827767237
   PubMed Web of Science ®Google Scholar
• Silva ALA, Martins LR, Cardoso BA, et al. IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias. Cancer Res. 2011;71(14):4780–4789. doi:10.1158/0008-5472.CAN-10-360621593192
   PubMed Web of Science ®Google Scholar
• Qu HZZ, Pan Z, Zhang T, Deng N, Chen G, Wang Z. IL-7/IL-7 receptor axis stimulates prostate cancer cell invasion and migration via AKT/NF-κB pathway. Int Immunopharmacol. 2016;40:203–210. doi:10.1016/j.intimp.2016.08.01727611862
   PubMed Web of Science ®Google Scholar
• Andersson A1SM, Harris-White M, Huang M, et al. Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancer. Clin Cancer Res. 2011;17(11):3660–3672. doi:10.1158/1078-0432.CCR-10-334621636553
   PubMed Web of Science ®Google Scholar
• Andersson AYS, Huang M, Zhu L, et al. IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung cancer. J Immunol. 2009;182(11):6951–6958. doi:10.4049/jimmunol.080334019454692
   PubMed Web of Science ®Google Scholar
• Jian MYZ, Zhiying D, Yanduo J, Guocheng J. Interleukin 7 receptor activates PI3K/Akt/mTOR signaling pathway via downregulation of Beclin-1 in lung cancer. Mol Carcinog. 2018. doi:10.1002/mc.22933
   PubMed Web of Science ®Google Scholar
• Liu ZHWM, Ren HJ, Qu W, et al. Interleukin 7 signaling prevents apoptosis by regulating bcl-2 and bax via the p53 pathway in human non-small cell lung cancer cells. Int J Clin Exp Pathol. 2014;7(3):870–881.24695377
   PubMed Web of Science ®Google Scholar
• Yan SSR, Wu S, Jin T, et al. Single nucleotide polymorphism in the 3ʹ untranslated region of LPP is a risk factor for lung cancer: a case-control study. BMC Cancer. 2019;19(1):35. doi:10.1186/s12885-018-5241-530621612
   PubMedGoogle Scholar
• Nikseresht MSM, Dehghani M, Abidi H, et al. Association of single nucleotide autophagy-related protein 5 gene polymorphism rs2245214 with susceptibility to non-small cell lung cancer. J Cell Biochem. 2018. doi:10.1002/jcb.27467
   PubMed Web of Science ®Google Scholar
• Van Dyke AL, Cote ML, Wenzlaff AS, et al. Cytokine and cytokine receptor single-nucleotide polymorphisms predict risk for non-small cell lung cancer among women. Cancer Epidemiol Biomarkers Prev. 2009;18(6):1829–1840. doi:10.1158/1055-9965.EPI-08-096219505916
   PubMed Web of Science ®Google Scholar
• Dai ZJLX, Kang HF, Wang XJ, et al. Genetic variation in metastasis-associated in colon cancer-1 and the risk of breast cancer among the chinese han population: a strobe-compliant observational study. Medicine. 2016;95(6):e2801. doi:10.1097/MD.000000000000486426871844
   PubMed Web of Science ®Google Scholar
• Xia PLB, Geng T, Deng Z, et al. FGFR2 gene polymorphisms are associated with breast cancer risk in the Han Chinese population. Am J Cancer Res. 2015;5(5):1854–1861.26175953
   PubMed Web of Science ®Google Scholar
• Dupont WD, Plummer WD Jr. Power and sample size calculations for studies involving linear regression. Control Clin Trials. 1998;19(6):589–601.9875838
   PubMedGoogle Scholar
• Cavic M, Spasic J, Krivokuca A, et al. TP53 and DNA-repair gene polymorphisms genotyping as a low-cost lung adenocarcinoma screening tool. J Clin Pathol. 2019;72(1):75–80. doi:10.1136/jclinpath-2018-20555330467244
   PubMed Web of Science ®Google Scholar
• Suzuki KKK, Sima CS, Nitadori J, et al. Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence. J Clin Oncol. 2013;31(4):490–498. doi:10.1200/JCO.2012.45.205223269987
   PubMed Web of Science ®Google Scholar
• Jian MQZ, Yanduo J, Guocheng J, Xueshan Q. Anti-lymphangiogenesis effects of a specific anti-interleukin 7 receptor antibody in lung cancer model in vivo. Mol Carcinog. 2015;54(2):148–155. doi:10.1002/mc.2208224115038
   PubMed Web of Science ®Google Scholar
• Ming JZQ, Qiu X, Wang E. Interleukin 7/interleukin 7 receptor induce c-Fos/c-Jun-dependent vascular endothelial growth factor-D up-regulation: a mechanism of lymphangiogenesis in lung cancer. Eur J Cancer. 2009;45(5):866–873. doi:10.1016/j.ejca.2008.12.00619136250
   PubMed Web of Science ®Google Scholar
• Ming JJG, Zhang Q, Qiu X, Wang E. Interleukin-7 up-regulates cyclin D1 via activator protein-1 to promote proliferation of cell in lung cancer. Cancer Immunol Immunother. 2012;61(1):79–88. doi:10.1007/s00262-011-1078-321847632
   PubMed Web of Science ®Google Scholar
• Kim JYCH, Kim HJ, Kim LH, Namgoong S, Shin HD. Association analysis of IL7R polymorphisms with inflammatory demyelinating diseases. Mol Med Rep. 2014;9(2):737–743. doi:10.3892/mmr.2013.186324337176
   PubMed Web of Science ®Google Scholar
• Heron MGJ, van Moorsel CH, Ruven HJ, Huizinga TW, van der Helm-van Mil AH, Claessen AM, van den Bosch JM. Variation in IL7R predisposes to sarcoid inflammation. Genes Immun. 2009;10(7):647. doi:10.1038/gene.2009.5519626041
   PubMed Web of Science ®Google Scholar
• Safaei SPZ, Moin M, Houshmand M. IL7R and RAG1/2 genes mutations/polymorphisms in patients with SCID. Iran J Allergy Asthma Immunol. 2011;10(2):129–132. doi:10.02/ijaai.12913221625022
   PubMed Web of Science ®Google Scholar
• Bao WLSH, Zhang AQ, Kong XM, Deng DH, Zhang YJ. Lack of associations of polymorphisms of IL-7R, IL-13 and IL-15 with NSCLCs in non-smoking Chinese. Asian Pac J Cancer Prev. 2011;12(12):3239–3244.22471460
   PubMedGoogle Scholar
• Wang YSC, Hough KP, Tousif S, et al. Myeloid-derived suppressor cells impair B cell responses in lung cancer through IL-7 and STAT5. J Immunol. 2018;201(1):278–295. doi:10.4049/jimmunol.170106929752311
   PubMed Web of Science ®Google Scholar
• Shiels MSPR, Hildesheim A, Engels EA, et al. Circulating inflammation markers and prospective risk for lung cancer. J Natl Cancer Inst. 2013;105(24):1871–1880. doi:10.1093/jnci/djt30924249745
   PubMedGoogle Scholar
• Suzuki TKH, Abe R. Requirement of interleukin 7 signaling for anti-tumor immune response under lymphopenic conditions in a murine lung carcinoma model. Cancer Immunol Immunother. 2016;65(3):341–354. doi:10.1007/s00262-016-1808-726880265
   PubMed Web of Science ®Google Scholar